The objective of this investigation was to assess the association of peak oxygen consumption (V O 2 ) with postoperative outcome in a prospective cohort of patients undergoing major lung resection for the treatment of lung cancer. Methods: Preoperative symptom-limited cardiopulmonary exercise testing (CPET) performed using cycle ergometry was conducted in 204 consecutive patients who had undergone pulmonary lobectomy or pneumonectomy. Peak V O 2 was tested for possible association with postoperative cardiopulmonary complications and mortality. Logistic regression analysis, validated by a bootstrap analysis, was used to adjust for the effect of other perioperative factors. The role of peak V O 2 in stratifying the surgical risk was further assessed in different groups of patients subdivided according to their cardiorespiratory status. Results: Logistic regression showed that peak V O 2 was an independent and reliable predictor of pulmonary complications (p ‫؍‬ 0.04). All six deaths occurred in patients with a peak V O 2 of < 20 mL/kg/min (four deaths in patients with a peak V O 2 of < 12 mL/kg/min). The mortality rate in this high-risk group was 10-fold higher (4 of 30 patients; 13%) compared to those with higher peak V O 2 (p ‫؍‬ 0.006). Compared to patients with a peak V O 2 of > 20 mL/kg/min, those with a peak V O 2 of < 12 mL/kg/min had 5-fold, 8-fold, 5-fold, and 13-fold higher rates, respectively, of total cardiopulmonary complications pulmonary complications, cardiac complications, and mortality. Conclusions: The present study supports a more liberal use of CPET before lung resection compared to the current guidelines since this test can help in stratifying the surgical risk and optimizing perioperative care.
C
ardiopulmonary exercise testing (CPET) has become an integral part of the preoperative workup of lung resection candidates because it is capable of revealing deficits in the oxygen transport system associated with postoperative complications. Although several studies 1, 2 have demonstrated that patients in whom complications develop have a reduced preop-erative aerobic capacity, the use of high-technology exercise tests with gas analyzers measuring oxygen consumption (V o 2 ) is usually recommended for selected patients only with impaired respiratory function. 3 Whether the systematic measurement of peak V o 2 can add to preoperative risk stratification has never been fully assessed.
Thus, we conducted this prospective trial in which all lung resection candidates underwent formal CPET with peak V o 2 measurement. The objectives of the study were twofold, as follows: (1) to evaluate whether and to what extent peak V o 2 was associated with postoperative cardiopulmonary morbidity and mortality; and (2) and to verify in which patients (subdivided according to their preoperative cardiorespiratory status) this parameter may change clinical practice and influence operability and outcome.
Materials and Methods
This was an observational analysis performed on prospective data collected from all 285 patients who underwent lung resection for lung cancer from January 2006 through June 2008. All patients gave their consent to participate in the protocol and to the use of their data for clinical and investigational purposes. The study and the database were both approved by the local institutional review board.
For the purpose of this investigation, our traditional preoperative functional evaluation protocol 4 was modified to include a symptom-limited incremental cardiopulmonary exercise test on a bike with V o 2 measurement in all lung resection candidates (Fig 1) . If patients had both a predicted postoperative FEV 1 (ppoFEV 1 ) of Ͻ 30% predicted and a predicted postoperative diffusing capacity of the lung for carbon monoxide (ppoDlco) of Ͻ 30% predicted in association with a peak V o 2 of Ͻ 10 mL/kg/min, a major lung resection was contraindicated, and lung-sparing procedures (eg, wedge resection or segmentectomy) or nonoperative options were considered, as appropriate. Figure  2 shows the flow of patients during the study period. Fifty-nine patients who underwent minor resection (eg, wedge resection or segmentectomy) and 204 patients (177 lobectomies and 27 pneumonectomies) who underwent major lung resections were able to undergo CPET in the preoperative evaluation.
As a rule, all operations were performed through a musclesparing lateral thoracotomy by qualified thoracic surgeons. All patients were managed in a dedicated thoracic ward with specialized personnel and were managed in the ICU only in case of cardiorespiratory complications requiring active life-supporting treatments. The postoperative treatment was standardized, with particular emphasis on chest physiotherapy, early mobilization, physical rehabilitation, and adequate epidural or IV analgesic therapy (which was titrated to keep the pain visual analog score below 4 [on a scale ranging from 0 to 10] during the first 48 to 72 h).
CPET
After a familiarization test, a symptom-limited cardiopulmonary exercise test was performed on an electronically braked cycle ergometer using a ramp-pattern increase in work rate to reach an exercise test duration of between 8 and 12 min. All of the exercise tests were performed in the morning at least 3 h after the patient had eaten a light breakfast. Expired gases and volumes were analyzed, breath by breath, with a metabolic cart (QUARK PFT; COSMED; Rome, Italy). Heart rate and BP were measured every minute during increasing work rate exercise and recovery. Recordings of heart rate were made using a 12-lead ECG every minute. The exercise test was stopped when one or more of the following criteria were present: fatigue; dyspnea; excessive systemic BP increase (ie, Ն 230/130 mm Hg); a Ն 2-mm ST 
Analysis
Outcomes: The following outcomes (occurring within 30 days postoperatively or for a longer period if the patient was still in the hospital) were analyzed: total cardiopulmonary morbidity; cardiac complications; pulmonary complications; and mortality. Their definitions are detailed in Table 1 and are consistent with those in previous studies. [5] [6] [7] Perioperative Variables: In addition to ergometric parameters and peak V o 2 , the following variables were tested for a possible association with outcomes: age; gender; body mass index (in kilograms per square meter); FEV 1 ; diffusing capacity of the lung for carbon monoxide (Dlco); ppoFEV 1 ; ppoDlco; coronary artery disease (CAD); type of operation (ie, lobectomy vs pneumonectomy); and neoadjuvant chemotherapy.
Pulmonary function tests were performed according to the American Thoracic Society criteria. The results of spirometry were collected after bronchodilator administration. Dlco measurement was performed by the single-breath method.
FEV 1 , ppoFEV 1 , Dlco, and ppoDlco were expressed as percentages of predicted values for age, gender, and height. The ppoFEV 1 and ppoDlco were calculated by taking into account the number of obstructed/unobstructed lung segments removed during surgery (estimated by bronchoscopy and CT scan). A quantitative lung perfusion scan was also performed in all pneumonectomy candidates according to published guidelines. 8 Statistical Analysis: Variables were initially screened by univariate analysis using an unpaired Student t test or the MannWhitney U test. Categorical variables were compared by means of the 2 test or the Fisher exact test, as appropriate.
Variables with a p value of Ͻ 0.10 at univariate analysis were then used as independent variables in stepwise logistic regression analyses (the dependent variables used were cardiovascular and pulmonary morbidity). Mortality was not separately analyzed with multivariate regression because of the small numbers (only six deaths). In morbidity analyses, cases of mortality were counted as complicated patients according to the type of complications that caused death. All data were complete. A p value of Ͻ 0.1 was selected for the retention of variables in the final model. Regression analyses were then validated by a bootstrap technique with 1,000 samples. 9 -11 A sensitivity/specificity analysis (c-index or receiver operating characteristic) was also performed to determine the best cutoff value of peak V o 2 either in absolute value and in the percentage of the predicted value.
All of the statistical tests were two tailed, and a significance level of 0.05 was accepted. The analysis was performed using a statistical software package (STATA, version 8.2; Stata Corp; College Station, TX). Table 2 shows the characteristics of the patients enrolled in the study. The morbidity and mortality rates after major lung resections were 23% (44 cases) and 3.1% (six cases), respectively. Forty-three pulmonary complications occurred in 28 patients, as follows: respiratory failure requiring assisted mechanical ventilation, 12 cases; atelectasis needing bronchoscopy, 9 cases; pneumonia, 14 cases; pulmonary edema, 3 cases; and ARDS, 5 cases. Twentynine cardiovascular complications occurred in 27 patients, as follows: arrhythmia, 24 cases; and cardiac failure, 5 cases. Ten patients had both cardiac and pulmonary complications. Figure 3 shows the proportion of patients with values of peak V o 2 within the commonly used cutoff values (Ͻ 10, 10 to 15, 15 to 20, and Ͼ 20 mL/kg/min). [1] [2] [3] 8, 12 Table 3 shows the ergometric parameters in patients with and without complications or mortality. The peak V o 2 was associated with total morbidity (p ϭ 0.07), pulmonary complications (p ϭ 0.015), and mortality (p ϭ 0.017). Although the association with cardiovascular complications did not reach statistical significance (p ϭ 0.3), we observed only one cardiac complication in patients with a peak V o 2 of Ͼ 20 mL/kg/min (3.5% vs 15%, respectively, predicted compared to patients with peak V o 2 of Ͻ 20 mL/kg/min; p ϭ 0.06). After adjusting the effects of other perioperative factors by stepwise logistic regression, V o 2 remained an independent and reliable predictor of pulmonary complications (p ϭ 0.04) [ Tables 4, 5] .
Results
We observed a total of six deaths among the 204 major lung resections performed (Table 6 ). All deaths occurred in patients with a peak V o 2 of Ͻ 20 mL/kg/min, and four of six deaths occurred in those with a peak V o 2 of Ͻ 12 mL/kg/min. The mortality rate in this high-risk group was 10-fold higher (4 of 30 patients; 13%) compared to those with a peak V o 2 Ͼ 12 Ͻ 20 mL/kg/min (2 of 160 patients; 1.2%; p ϭ 0.006 [Fisher exact test]) [Fig 4] . Moreover, compared to patients with a peak V o 2 Ͼ 20 mL/kg/min those with a peak V o 2 Ͻ 12 mL/kg/min had fivefold and eightfold higher rates, respectively, of total cardiopulmonary and pulmonary complications (Fig 4) .
V O 2 Percent Predicted
Receiver operating characteristic analyses showed that the best absolute and percent predicted cutoff values for pulmonary complications were 12 mL/kg/ min and 40% predicted (c-indices, 0.58 vs 0.55, respectively; p ϭ 0.4). For mortality, the best cutoff values were 12 mL/kg/min and 50% predicted, respectively (c-indexes, 0.76 vs 0.65, respectively; p ϭ 0.15).
FEV 1 and DLCO Ͼ 80% Predicted
Sixty-eight patients had both FEV 1 and Dlco Ͼ 80% predicted. No death occurred in this group, and the morbidity rate was 13% (nine cases). The mean peak V o 2 did not differ between patients with complications and those without complications (15.6 vs 16.6 mL/kg/min, respectively; p ϭ 0.2).
FEV 1 and/or DLCO Ͻ 80% Predicted
Most of the patients had FEV 1 , Dlco, or both Ͻ 80% (136 cases). Among these patients, those with both ppoFEV 1 and ppoDlco Ͼ 40% (113 patients) had morbidity and mortality rates of 27% (30 cases) and 4.4% (5 cases), respectively. Three of the five deaths occurred in patients with a peak V o 2 between 10 and 12 mL/kg/min.
Those patients with a ppoFEV 1 , ppoDlco, or both Ͻ 40% predicted (23 cases; 13 lobectomies and 10 pneumonectomies) had morbidity and mortality rates of 22% (5 cases) and 4.3% (one death), respectively. The only death occurred in a patient with a peak V o 2 of Ͻ 12 mL/kg/min.
Among the 10 patients with either a ppoFEV 1 of Ͻ 30% predicted or a predicted postoperative product (ie, ppoDlco percent predicted ϫ ppoFEV 1 percent predicted) of Ͻ 1,650, 12 who were deemed to be at increased risk according to the revised American College of Chest Physicians criteria, 3 there was no mortality and just one complication. All of these patients were operated on owing to their peak V o 2 of Ͼ 10 mL/kg/min (five patients, Ͼ 15 mL/kg/min; five patients, 10 to 15 mL/kg/min).
Ten patients in this group had a peak V o 2 of Ͻ 10 mL/kg/min. Six of the patients were operated on (four wedge resections and two lobectomies; one death; and *Values are given as the mean (SD). HRR ϭ heart rate reserve (maximal predicted heart rate Ϫ peak heart rate/maximal predicted heart rate ϫ 100); VE ϭ expired ventilation; BR ϭ breathing reserve (maximum voluntary ventilation Ϫ VE); Vd/Vt ϭ physiologic dead space ventilation; O 2 pulse ϭ V o 2 /peak heart rate ratio; AT ϭ anaerobic threshold. †p Ͻ 0.1. ‡p Ͻ 0.05. two patients with complications), whereas the conditions of four of the patients were deemed to be inoperable (ie, both ppoFEV 1 and ppoDlco were Ͻ 30% predicted, so no minor resection was possible).
Cardiac Disease
Thirty-one patients with CAD and 4 patients with a history of cardiac failure underwent major lung resections. All of these patients had a peak V o 2 of Ͼ 10 mL/kg/min. In this group, there were 11 patients with complications (31%) and 3 patients who died (8.6%). All deaths occurred in patients with a peak V o 2 Ͻ 12 mL/kg/min (two lobectomies and one pneumonectomies). In three patients (all with FEV 1 or Dlco Ͻ 80% predicted) with a negative history of CAD, findings at cycle ergometry revealed CAD. All of these patients underwent lobectomy after the introduction of therapy with ␤-blockers, and their outcomes were uneventful.
Minor Resections
No mortality and eight complications (13%) were observed among the patients who underwent wedge resections or segmentectomies. Six of these patients underwent surgery despite a peak V o 2 of Ͻ 10 mL/kg/ min, and 40 patients underwent surgery despite severe cardiovascular comorbidities (ejection fraction, Ͻ 30%), respiratory comorbidities (ppoFEV 1 and/or ppoDlco, Ͻ 30% predicted), or systemic comorbidities (recent stroke, renal insufficiency, or liver cirrhosis) for their satisfactory performance during CPET (peak V o 2 , Ͼ 10 mL/kg/min), even though 27 patients had a peak V o 2 of Ͻ 15 mL/kg/min.
Discussion
We were able to confirm previous findings [1] [2] [3] 8, 13 that a peak V o 2 of Ͼ 20 mL/kg/min is a safe cutoff value for major lung resection. In fact, no mortality and only 3.5% of pulmonary and cardiac morbidity rates were observed above this threshold. On the other hand, we found that in the group of patients with a peak V o 2 of Ͻ 12 mL/kg/min the mortality and morbidity rates were excessively high (13% and 33%, respectively). In particular, pulmonary morbidity was eightfold higher than that in patients with a peak V o 2 Ͼ 20 mL/kg/min. For cardiac morbidity, the risk stratification was less clear. At V o 2 values Ͻ 20 mL/kg/min, all patients had approximately the same risk. This may be explained by the fact most of Table 2 for abbreviation not used in the text. Only significant factors are shown. the cardiac complications were arrhythmia, unlikely to be influenced by a reduced V o 2 . Logistic regression and bootstrap analyses confirmed that peak V o 2 was an independent predictor of pulmonary morbidity (which was also the leading cause of death in this series) along with a reduced ppoFEV 1 , emphasizing the importance of using both parameters for risk stratification. [1] [2] [3] Contrary to previous reports, 14,15 we were not able to confirm that peak V o 2 expressed as percentage of predicted values was a better predictor of complications than when expressed in absolute values. More liberal selection criteria (85 patients with a peak V o 2 of Ͻ 15 mL/kg/min) and a different case mix may contribute to explaining this discrepancy.
As CPET was performed in all patients irrespective of their respiratory function, we were able to assess how much this test added to the preoperative risk stratification in relationship to different groups defined according to the criteria of the most recent functional guidelines. 3 These guidelines recommended exercise testing only in very select patients (ppoFEV 1 or ppoDlco Ͻ 40% predicted).
In this regard, the following inferences can be drawn from our results:
1. Patients with both FEV 1 and Dlco values Ͼ 80% predicted had a low operative risk, and CPET did not add to their risk stratification. 2. Among those patients with either FEV 1 or Dlco Ͻ 80% predicted, but both ppoFEV 1 and ppoDlco Ͼ 40% predicted, there were five deaths, three of which occurred in patients with a peak V o 2 Ͻ 12 mL/kg/min. Moreover, in this group CPET revealed unsuspected and asymptomatic CAD in three patients who were consequently treated and uneventfully underwent surgery. Thus, we believe that CPET should be performed in these patients as it can influence perioperative management. 3. We found that patients with ppoFEV 1 , ppoDlco, or both Ͻ 40% predicted can tolerate major lung resection with acceptable morbidity and mortality rates if their peak V o 2 was Ͼ 10 mL/kg/min. In these patients, peak V o 2 measurement appears therefore to be of paramount importance for selecting the most appropriate treatment option. 4. Even those patients with a ppoFEV 1 Ͻ 30% predicted or postoperative predicted product Ͻ 1,650, who traditionally have been deemed to be at prohibitive risk for surgery, 3 underwent major lung resection safely in cases where the peak V o 2 was Ͼ 10 mL/kg/min. Thus, CPET should be always performed in these patients to definitively exclude them from surgery. 5. In our view, CPET should be also performed in all patients with a known CAD, irrespective of their respiratory function, because we found that it is associated with outcome and can influence operability and perioperative management. 6. CPET should be also performed in all of those patients with severe cardiac, respiratory, and systemic comorbidities, whose conditions are often deemed to be inoperable, because a sufficient aerobic reserve in these patients can lead to an acceptable postoperative outcome after they un- dergo lung-sparing procedures (whenever technically and oncologically feasible).
Although this was a large, prospectively collected, homogeneous series of major lung resections, this study may have potential limitations that need to be taken into account when interpreting the results. First, as this was an observational analysis performed on prospective data, the results may have been influenced by selection bias. Although our exclusion criteria for major lung resection were less restrictive than the most commonly used guidelines, 3, 8 no inferences can be drawn from our data about whether peak V o 2 values Ͻ 10 mL/kg/min represent an absolute contraindication to major resection. Second, the present findings were obtained in a dedicated thoracic surgery center. Caution should be paid in generalizing these findings to nonspecialist settings without standardized pathways of care.
In conclusion, we found that peak V o 2 was reliably associated with pulmonary complications and death after major lung resection. The results of this study support a more liberal use of CPET during the preoperative functional workup of lung resection candidates compared to the most recent functional guidelines. 3, 8 The interpretation of CPET findings may in fact assist in optimizing the clinical pathways of care of lung cancer patients.
